NASDAQ:BCRX   BioCryst Pharmaceuticals, Inc.
Entry price: 8.27

Fundamentals:

- Sector: Medical - Biotech

- EPS % Chg (Last Qtr): 24%

- EPS % Chg (Previous Qtr): 24%%

- 3 Year EPS Growth Rate: 0%

- EPS Est % Chg (Current Yr): 0%

- Sales % Chg (Last Qtr): 243%

- Sales % Chg (Previous Qtr): 98%

- 3-Year Sales Growth Rate: 25%

- Annual Pre -Tax Margin: -223%
评论:
Added
Average price: 7.99
评论:
_________________________
- EPS % Chg (Last Qtr): -1600%
- Sales % Chg (Last Qtr): -90%
评论:
Sold at 11.04
Return: +38.06%
评论:

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。